---
title: "Adma Biologics (ADMA.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ADMA.US/norm.md"
symbol: "ADMA.US"
name: "Adma Biologics"
parent: "https://longbridge.com/en/quote/ADMA.US.md"
datetime: "2026-05-20T14:41:18.413Z"
locales:
  - [en](https://longbridge.com/en/quote/ADMA.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ADMA.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ADMA.US/norm.md)
---

# Adma Biologics (ADMA.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | 0.1900 | 0.1999 | 0.1500 | 0.1400 | 0.1100 |
| ROE | 41.79% | 43.48% | 35.13% | 35.47% | 29.79% |
| Revenue | 114.49M | 139.16M | 134.22M | 121.98M | 114.80M |
| Net income | 45.33M | 49.38M | 36.43M | 34.22M | 26.90M |
| Operating income | 50.29M | 62.75M | 51.01M | 42.80M | 34.88M |
| Gross margin | 70.53% | 63.82% | 56.34% | 55.11% | 53.22% |
| Net margin | 39.59% | 35.48% | 27.14% | 28.05% | 23.44% |
| Profit quality | 86.34% | 176.07% | 383.75% | 202.46% | -177.29% |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 665.18M | 624.24M | 568.69M | 558.38M | 510.57M |
| Leverage | 1.70 | 1.31 | 1.32 | 1.40 | 1.37 |
| BVPS | 1.68 | 2.01 | 1.81 | 1.67 | 1.57 |
| Turnover | 0.8673 | 0.9168 | 1.02 | 1.01 | 1.07 |
| Cash & STI | 138.15M | 87.63M | 61.38M | 90.28M | 71.63M |
| Inv & Rec | 222.10M | 206.47M | 196.67M | 191.46M | 172.19M |
| LT assets | 71.41M | 71.71M | 78.78M | 66.46M | 65.73M |
| Net debt | 66.25M | -7.75M | 21.74M | -6.46M | 10.39M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | 58.25M | 35.64M | 13.29M | 21.14M | -19.68M |
| Investing CF | 2.40M | -276000.00 | -14.37M | -2.53M | -4.72M |
| Financing CF | -10.13M | -9.12M | -27.82M | 48000.00 | -7.13M |
| Free CF | 46.32M | 20.55M | -28.37M | 23.66M | -30.27M |
| OCF coverage | 1933.90% | 2294.85% | 14.80% | 65.20% | -418.53% |
| Repaid & issued | 125.00M | 0.0000 | 75.00M | 30.00M | - |
| CapEx | -2.54M | -1.08M | -14.37M | -2.42M | -4.70M |